AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
Migrate infobox: document_type -> document_category; add specific form as document_type |
||
| (6 intermediate revisions by the same user not shown) | |||
Line 4:
| period = FY
| period_label = FY25
|
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
* ''AXA
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
*
* ''
** APMs
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
=== Table of contents ===
*
*
*
== FY25 Highlights ==
*
=== Full Year 2025 | Excellent performance ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-
|-
| style="text-align:left" | Revenues growth vs. FY24
|
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
|
|-
| style="text-align:left" | Return on equity
|
|-
| style="text-align:left" | Solvency II ratio
|
|-
| style="text-align:left" | DPS growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" |
|
|}
</div>
* Dividend
* Share buyback approved by
=== Executing the plan on growth, margin and efficiency ===
Line 87 ⟶ 90:
|}
</div>
*
* Record profitability:
* Scaling the business:
*
=== Diversified franchise, well positioned in an attractive industry ===
Line 96 ⟶ 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 107 ⟶ 110:
|-
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
*
*
** Leading brand & high customer NPS
** Strong and diversified distribution
Line 126 ⟶ 129:
=== Laying the foundation for the next plan ===
*
**
**
**
**
*
==
=== FY25 business performance ===
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
=== Strong delivery across our businesses ===
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
<div style="overflow-x:auto">
{| class="wikitable
|+
! style="text-align:left" |
! class="col-
! class="col-
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|}
</div>
=== P&C | Strong margins, confidence in sustaining growth ===
* ''Gross written premiums'' (GWP) reached EUR 58bn <sup>p. 11</sup>.
* (donut) ''GWP mix'': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
* ''Retail and SME & Mid-market'' strategic outlook:
** ''2025'': Growing volumes while expanding margins <sup>p. 11</sup>.
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
* ''AXA XL (Large & Specialty)'' strategic outlook:
** ''2025'': Profitable growth with stable margins <sup>p. 11</sup>.
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
* ''Earnings drivers'' supporting performance:
** Continued progress on efficiency <sup>p. 11</sup>.
** Higher investment income <sup>p. 11</sup>.
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
=== L&H | Good momentum, well positioned to capture growth opportunities ===
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
* ''Short-term business'' strategic priorities:
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
* ''Strategic levers'' for growth and efficiency:
** Focus on cost reduction <sup>p. 12</sup>.
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
== Financial Performance ==
=== FY25
*
=== P&C | Continued disciplined growth ===
Line 257 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & other revenues by segment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 294 ⟶ 253:
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 306 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0%
|-
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%
|-
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
*
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
*
*
*
* Reserve prudence enhanced by taking advantage of a good year
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 376 ⟶ 333:
|}
</div>
*
*
*
*
*
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 386 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" |
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
Line 403 ⟶ 358:
| style="text-align:right" | 17.3
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-linked
Line 409 ⟶ 363:
| style="text-align:right" | 9.3
| style="text-align:right" | +13%
|-
| style="text-align:left" | Capital light G/A
Line 415 ⟶ 368:
| style="text-align:right" | 9.0
| style="text-align:right" | +7%
|-
| style="text-align:left" | Traditional G/A
Line 421 ⟶ 373:
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left" |
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
| style="text-align:right" | +5%
|-
| style="text-align:left" | Individual
Line 439 ⟶ 383:
| style="text-align:right" | 10.5
| style="text-align:right" | +6%
|-
| style="text-align:left" | Group
Line 445 ⟶ 388:
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | —
| style="text-align:right" | 1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|}
</div>
Line 459 ⟶ 433:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 465 ⟶ 439:
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
Line 489 ⟶ 463:
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" |
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" |
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|}
</div>
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 514 ⟶ 495:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
Line 544 ⟶ 525:
</div>
*
*
*
*
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 559 ⟶ 539:
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 574 ⟶ 554:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
*
* ''
* ''
* ''
* ''
* ''Life underlying earnings'' +4% to EUR 2.7bn (prior: EUR 2.6bn) <sup>p. 20</sup>
* ''Health underlying earnings'' +17% to EUR 0.8bn (prior: EUR 0.7bn) <sup>p. 20</sup>
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 591 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Earnings
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 615 ⟶ 597:
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" |
|-
| style="text-align:left" | ''Underlying earnings''
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
Line 624 ⟶ 606:
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" |
| style="text-align:right" |
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | ''Net income''
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
Line 641 ⟶ 628:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
| style="text-align:right" | 3.59
|-
| style="text-align:left" | Earnings growth
Line 653 ⟶ 643:
| style="text-align:left" | Forex
| style="text-align:right" | -2%
|-
| style="text-align:left" | Temporary earnings dilution from AXA IM sale
| style="text-align:right" | -1%
|-
| style="text-align:left" | FY25
| style="text-align:right" | 3.86
|}
</div>
*
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* ''Net income'' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
*
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
=== Shareholders'
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''
** ''
* ''
* ''
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | -
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | 0.3
|-
| style="text-align:left" | ''Closing Shareholders' equity''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
=== Higher organic cash remittance and robust cash position at Holding ===
* (bar) ''Net cash remittance'' trend:
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
** ''FY25'': EUR 7.5bn total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge FY24 to FY25 in Euro billion <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
Line 742 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
Line 753 ⟶ 768:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | EOF
! class="col-s" style="text-align:right" | SCR
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
| style="text-align:left" | FY24
| style="text-align:right" | 55.9
| style="text-align:right" | 25.9
| style="text-align:right" | 216
|-
| style="text-align:left" | Regulatory & model changes
| style="text-align:right" | +0.2
| style="text-align:right" | 0.0
| style="text-align:right" | +0
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +8.8
| style="text-align:right" | +0.6
| style="text-align:right" | +28
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.4
| style="text-align:right" | 0.0
| style="text-align:right" | -1
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
| style="text-align:right" | +2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 56.4
| style="text-align:right" | 25.2
| style="text-align:right" | 224
|}
</div>
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 822 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (
| style="text-align:right" | +2
|-
Line 839 ⟶ 855:
</div>
* Euro
* Credit rating migration sensitivity assumes 20% of corporate bonds
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 846 ⟶ 862:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -
|-
| style="text-align:left" | Solvency II revision impact
| style="text-align:right" | +
|}
</div>
Line 867 ⟶ 880:
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
*
* ''
=== Thomas Buberl, Group CEO conclusion ===
* ''
=== Conclusion ===
*
* ''
*
* ''
=== February 26, 2026 Q&A Full Year 2025 earnings ===
*
=== AXA Investor Relations | Keep in touch ===
*
*
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Date
! class="col-m" style="text-align:right" | Event
! class="col-m" style="text-align:right" | Location
|-
| style="text-align:left" | March
| class="col-m" style="text-align:right" | Roadshows
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
== Appendices ==
* Section divider
=== Table of contents ===
* ''
* ''
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | 4.8
| style="text-align:right" | 4.6
| style="text-align:right" | 3.2
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | 10.8
| style="text-align:right" | 12.2
| style="text-align:right" | 11.3
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 19.2
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2028
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
=== General account invested assets ===
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets breakdown FY25 <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
=== Structured and private credit assets ===
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right" | o/w 54% participating
|}
</div>
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
=== Investment portfolio | Fixed
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Fixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | 3.9%
|}
</div>
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
* Reinvestment
** Average duration of 9 years <sup>p. 35</sup>
** Private & Structured Credit reinvestment of EUR 19.7bn at 4.7% yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>
** Strategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
=== Table of contents ===
* ''
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,102 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business
! style="text-align:left" |
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Casualty
Line 1,120 ⟶ 1,312:
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
Line 1,134 ⟶ 1,331:
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup>
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup>
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
=== P&C | Focus on reserves ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and
! style="text-align:left" | %
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" |
| style="text-align:right" | 179
| style="text-align:right" | 185
| style="text-align:right" | 193
| style="text-align:right" | 188
| style="text-align:right" | 189
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 175
|-
| style="text-align:left" |
| style="text-align:right" | 213
| style="text-align:right" | 227
| style="text-align:right" | 233
| style="text-align:right" | 226
| style="text-align:right" | 227
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234
| style="text-align:right" | 232
| style="text-align:right" | 216
| style="text-align:right" | 210
|}
</div>
* Technical reserves
=== P&C | 2026 Simplified Group Nat Cat
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 600m
| style="text-align:right" | 4.0bn
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 450m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 400m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | Per other perils
| style="text-align:right" | 400m
| style="text-align:right" | Varies by peril type
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram) ''Reinsurance segment'' (illustrative):
*
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Return period / probability percentile
! class="col-s" style="text-align:right" | EUR billion
|-
| style="text-align:left" | 1/20y (95th percentile)
| style="text-align:right" | -1.2
|-
| style="text-align:left" | 1/10y (90th percentile)
| style="text-align:right" | -0.8
|-
| style="text-align:left" | 1/5y (80th percentile)
| style="text-align:right" | -0.4
|-
| style="text-align:left" | Median (50th percentile)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 1/5y (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | EUR billion
! class="col-s" style="text-align:right" | Estimated impact on GEP
|-
| style="text-align:left" | 2025
| class="col-s" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | ca. 4.5%
|-
| style="text-align:left" | 2026
| class="col-s" style="text-align:right" | 2.7
| class="col-s" style="text-align:right" | ca. 4.5%
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
=== Table of contents ===
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== P&C | Margin analysis ===
Line 1,272 ⟶ 1,526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C margin analysis
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" |
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" |
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" |
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" |
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" |
| style="text-align:right" | 8,040
| style="text-align:right" | +681
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates,
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" |
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|}
</div>
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
=== L&H | Margin analysis ===
* ''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 479
| style="text-align:right" | +60
|-
| style="text-align:left" |
| style="text-align:right" | 2,804
| style="text-align:right" | +156
|-
| style="text-align:left" |
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" |
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
</div>
{| class="wikitable fintable"
|+ Underlying earnings bridge in Euro million <sup>p. 43</sup>
! style="text-align:left" | Underlying Earnings
|-
| style="text-align:left" |
| style="text-align:right" | 4,229
| style="text-align:right" | +205
|-
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" |
|-
| style="text-align:left" | Affiliates,
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" |
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|}
</div>
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Baseline
Line 1,549 ⟶ 1,662:
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Sovereign spreads +50bps
Line 1,555 ⟶ 1,668:
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Corporate spread +50bps
Line 1,561 ⟶ 1,674:
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" |
|-
| style="text-align:left" | Equities -25%
Line 1,570 ⟶ 1,683:
|}
</div>
* ''Sustainability'' <sup>p. 44</sup>
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,582 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" |
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" |
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | EUR 5bn per year
| class="col-m" style="text-align:right" | EUR 6.4bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | -
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | 56%
|}
Line 1,634 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG ratings
! style="text-align:left" | Rating Agency
! class="col-
|-
| style="text-align:left" | S&P Global percentile
| class="col-
|-
| style="text-align:left" | MSCI
| class="col-
|-
| style="text-align:left" | CDP
| class="col-
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-
|-
| style="text-align:left" | FTSE Russell
| class="col-
|}
</div>
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
=== Scope ===
*
*
*
*
**
**
**
**
*
*
*
=== Glossary ===
*
*
*
*
*
*
*
*
*
*
*
*
*
=== February 26, 2026 Thank you Full Year 2025 earnings ===
* ''Closing slide'' for the AXA Full Year 2025 Earnings
== Abbreviations ==
*
*
*
*
*
* ''AMF'': Autorité des marchés financiers
* ''
* ''
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* ''
* ''
* ''
* ''
* ''
* ''
* ''
* ''
* ''
* ''EME'': Emerging Markets
* ''
* ''
* ''ESG'': Environmental, Social, and Governance
* ''ESMA'': European Securities and Markets Authority
* ''
* ''
* ''
* ''GAAP'': Generally Accepted Accounting Principles
* ''GBP'': Great British Pound
* ''
* ''
* ''
* ''
* ''
* ''IFRS'': International Financial Reporting Standards
* ''
* ''JPY'': Japanese Yen
* ''
* ''LFL'': Like-for-Like
* ''
* ''MSCI'': Morgan Stanley Capital International
* ''
* ''NB CSM'': New Business Contractual Service Margin
* ''
* ''
* ''
* ''
* ''
* ''
* ''PVEP'': Present Value of Expected Profits
* ''PYD'': Prior Years' Reserve Development
* ''RCG'': Reinsurance Capital Generation
* ''
* ''
* ''
* ''
* ''
* ''UEPS'': Underlying Earnings Per Share
* ''UK'': United Kingdom
* ''US'': United States
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach
| |||